Inhibition of the slow pressor effect of angiotensin II contributes to the antihypertensive effect of angiotensin-converting enzyme inhibitors in renovascular hypertension

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 1, 1996, Pages 297-303

  Melaragno, Matthew G ^a   Fink, Gregory D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRINKING WATER; ENALAPRIL MALEATE; LOSARTAN; MINOXIDIL; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG INHIBITION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY ARTERY STENOSIS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTENSION; MALE; RATS; RATS, SPRAGUE-DAWLEY; URINATION;

EID: 0030425584     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. ATKINSON, A. B., BROWN, J. J., DAVIES, D. L., LECKIE, B., LEVER, A. F., MORION, J. J. AND ROBERTSON, J. I. S.: Renal artery stenosis with normal angiotensin II values: relationship between angiotensin II and body sodium and potassium on correction of hypertension by captopril and subsequent surgery. Hypertension 3: 53-58, 1981.
2. BAO, G., GOHLKE, P., QADRI, F. AND UNGER, T.: Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril. Hypertension 20: 74-79, 1992.
3. BROWN, A. J., CASALA-STENZEL, J. GOFFORD, S., LEVER, A. F. AND MORTON, J. J.: Comparison of fast and slow presser effects of angiotensin II in the conscious rat. Am. J. Physiol. 241: H381-H388, 1981.
4. CLOZEL, M., KUHN, H. AND HEFTI, F.: Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. Hypertension 16: 532-540, 1990.
5. COWLEY, A. W. AND DECLUE, J. W.: Quantification of baroreceptor influence on arterial pressure changes seen in primary angiotensin-induced hypertension in dogs. Circ. Res. 39: 779-787, 1976.
6. DECLUE, J. W., GUYTON, A. C., COWLEY, A. W., COLEMAN, T. G., NORMAN, R. A. AND MCCAA, R. E.: Subpressor angiotensin infusion, renal sodium handling, and salt-induced hypertension in the dog. Circ. Res. 43: 503-512, 1978.
7. DERKX, F. H. M. AND SCHALEKAMP, M. A. D. H.: Renal artery stenosis and hypertension. Lancet 344: 237-239, 1994.
8. DZAU, V. J. AND RE, R.: Tissue angiotenein system in cardiovascular medicine: A paradigm shift? Circulation 89: 493-498, 1994.
9. GORBEA-OPPLIGER, V. J., MELARAGNO, M. G., POTTER, G. S., PETIT, R. L. AND FINK, G. D.: Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast presser effects. J. Pharmacol. Exp. Ther. 271: 804-810, 1994.
10. HARRAP, S. B., VAN DER MERWE, W. M., GRIFFIN, S. A., MACPHERSON, F. AND LEVER, A. F.: Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 16: 603-614, 1990.
11. 1 receptor antagonist. Br. J. Pharmacol. 111: 137-144, 1994.
12. HODSMAN, G. P., BROWN, J. J., CUMMING, A. M. M., DAVIES, D. L., EAST, B. W., LEVER, A. F., MORTON, J. J., MURRAY, G. D. AND ROBERTSON, J. I. S.: Enalapril in treatment of hypertension with renal artery stenosis. Am. J. Med. 77: Suppl. 2A, 52-60, 1984.
13. IMAMURA, A., MACKENZIE, H. S., LACY, E. R., HUTCHISON, F. N., FITZGIBBON, W. R. AND PLOTH, D. W.: Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats. Kidney Int. 47: 1394-1402, 1995.
14. LEVER, A. F.: The fast and slowly developing presser effect of angiotensin II. In The Renin-Angiotensin System, ed. by J. I. S. Robertson and M. G. Nicholls, pp. 28.1-28.9, Gower Medical Publishing, London, 1993.
15. 1 receptor antagoniat CV-11974 in conscious renal hypertensive rats. Hypertension 26: 989-997, 1995.
16. MARKS, E. S., THURSTON, H., BING, R. F. AND SWALES, J. D.: Presser responsiveness to angiotensin II in renovascular and steroid hypertension. Clin. Sci. 57: 47S-50S, 1979.
17. MCAREAVEY, D., BROWN, W. B. AND ROBERTSON, J. I. S.: Exchangeable sodium in rats with Goldblatt two-kidney one-clip hypertension. Clin. Sci. 63:271-274, 1982.
18. + permeability. J. Pharmacol. Exp. Ther. 245: 751-760, 1988.
19. MELARAGNO, M. G. AND FINK, G. D.: Enhanced slow presser effect of angiotensin II in two- kidney, one clip rats. Hypertension 25: 288-293, 1995.
20. MELARAGNO, M. G. AND FINK, G. D.: Slow pressor effect of angiotensin II in normotensive rats with renal artery stenosis. Clin. Exp. Pharmacol. Physiol. 23: 140-144, 1996.
21. MÖHRING, J., MÖHRING, B., NÄUMANN, H. J., PHILIPPI, A., HOMSY, E., ORTH, H., DANDA, G., KAZDA, S. AND GROSS, F.: Salt and water balance and rerun activity in renal hypertension of rats. Am. J. Physiol. 228: 1847-1855, 1975.
22. MORTON, J. J. AND WALLACE, E. C. H.: The importance of the renin angiotensin system in the development and maintenance of hypertension in the two-kidney, one-clip hypertensive rat. Clin. Sci. 64: 359-370, 1983.
23. NIDDERBERGER, M., AUBERT, J.-F., NUSSBERGER, J., BRUNNER, H. R. AND WAEBER, B.: Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist. J. Hypertens. 13: 439-445, 1995.
24. NISHIMURA, M., MILSTED, A., BLOCK, C. H., BROSNIHAN, K. B. AND FERRARIO, C. M.: Tissue renin-angiotensin systems in renal hypertension. Hypertension 20: 158-167, 1992.
25. OKAMURA, T., MIYAZAKI, M., INAGAMI, T. AND TODA, N.: Vascular renin-angiotensin system in two-kidney, one clip hypertensive rats. Hypertension 8: 560-565, 1986.
26. ROBERTSON, J. I. S.: Renin and the pathophysiology of renovascular hypertension. In The Renin-Angiotensin System, ed. by J. I. S. Robertson and M. G. Nicholls, pp. 55.1-55.34, Gower Medical Publishing, London, 1993.
27. SCHRÖR, K.: Role of prostaglandins in the cardiovascular effects of bradykinin and angiotensin-converting enzyme inhibitors. J. Cardiovasc. Pharmacol. 20: suppl. 9, S68-S73, 1992.
28. SKULAN, T. W., BROUSSEAU, A. C. AND LEONARD, K. A.: Accelerated induction of two-kidney hypertension in rats and renin-angiotensin sensitivity. Circ. Res. 35: 734-741, 1974.
29. TEN BERG, R. AND DE JONG, W.: Mechansim of enhanced blood pressure rise after reclipping following removal of a renal artery clip in rats. Hypertension 2: 4-13, 1980.
30. THURSTON, H.: Goldblatt, coarctation, and Page experimental models of reno-vascular hypertension. In Textbook of Hypertension, ed. by J. D. Swales, pp. 477-493, Blackwell Scientific Publications, Oxford, 1994.
31. VON LUTTEROTTI, N., CATANZARO, D. F., SEALY, J. E. AND LARAOH, J. H.: Renin is not synthesized by cardiac and extrarenal vascular tissues: A review of experimental evidence. Circulation 89: 458-470, 1994.
32. WALLACE, E. C. H., BALMFORTH, A. J. AND MORTON, J. J.: Effect of acute and chronic captopril infusion on blood pressure in the two-kidney, one clip hypertensive rat. J. Hypertens. 3: 607-612, 1985.
33. WONG, P. C., PRICE, W. A., CHIU, A. T., DUNCIA, J. V., CARINI, D. J., WEXLER, R. R., JOHNSON, A. L. AND TIMMERMANS, P. B. M. W. M.: Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent. J. Pharmacol. Exp. Ther. 252: 726-732, 1990a.
34. WONG, P. C., PRICE, W. A., CHIU, A. T., DUNCIA, J. V., CARINI, D. J., WEXLER, R. R., JOHNSON, A. L. AND TIMMERMANS, P. B. M. W. M.: Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats: Nonpeptide angiotensin II receptor antagonists. X. Hypertension 15: 459-468, 1990b.
35. 2+ fluxes in aortic smooth muscle. Hypertension 22: 806-811, 1993.